Stay updated on CAcTUS: ctDNA-Guided Switch Clinical Trial
Sign up to get notified when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.

Latest updates to the CAcTUS: ctDNA-Guided Switch Clinical Trial page
- Check7 days agoChange DetectedThe page now lists Melanoma and related topics including MedlinePlus Genetics as related topics; this adds context for the condition but does not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.4.2 is now displayed, and older notices such as the funding lapse message and references to melanoma-related topics were removed. No study content, eligibility criteria, or user actions are changed.SummaryDifference0.6%

- Check21 days agoChange DetectedA minor funding-status notice and a version update (v3.4.1, replacing v3.4.0) were added.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI and metadata updates include showing the glossary, adding the label 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', removing the 'Last Update Submitted that met QC Criteria' label, and updating the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded related topic links for Melanoma and MedlinePlus Genetics to the Study Details page, enhancing navigational context. No core trial information, eligibility criteria, or outcomes are changed.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be a minor maintenance update that does not affect study details or patient information.SummaryDifference0.1%

Stay in the know with updates to CAcTUS: ctDNA-Guided Switch Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.